Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 16, Supplement E, July 1995   [Index by Author] 


Down List of Contributors
Down Foreword
Down Atheroma Regression
Down The Role of Aspirin in Primary Prevention
Down The Internal Mammary Artery or Saphenous Vein?
Down Angioplasty or Surgery?
Down Anti-Anginal Therapy after Infarction
Down ACE Inhibitors in MI
Down Treatment of Asymptomatic Ventricular Arrhythmias
Down Prognostic Effects of Modern Therapies


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

List of Contributors Back

List of contributors
Eur Heart J 1995 16: ii; doi:10.1093/eurheartj/16.suppl_E.ii [PDF] [Request Permissions]  

Foreword Back

D. G. Julian
Foreword
Eur Heart J 1995 16: 1; doi:10.1093/eurheartj/16.suppl_E.1 [PDF] [Request Permissions]  

Atheroma Regression Back

B. G. Brown, X.-Q. Zhao, D. Poulin, and J. J. Albers
Regression of atherosclerosis: Does it occur and does it have clinical meaning?
Eur Heart J 1995 16: 2-5; doi:10.1093/eurheartj/16.suppl_E.2 [PDF] [Request Permissions]  

V. Fuster and J. J. Badimon
Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram
Eur Heart J 1995 16: 6-12; doi:10.1093/eurheartj/16.suppl_E.6 [PDF] [Request Permissions]  

The Role of Aspirin in Primary Prevention Back

F. W. A. Verheugt
Aspirin and myocardial infarction: Is one positive study enough?
Eur Heart J 1995 16: 13-15; doi:10.1093/eurheartj/16.suppl_E.13 [PDF] [Request Permissions]  

V. Fuster and J. H. Chesebro
Aspirin for primary prevention of coronary disease
Eur Heart J 1995 16: 16-20; doi:10.1093/eurheartj/16.suppl_E.16 [PDF] [Request Permissions]  

The Internal Mammary Artery or Saphenous Vein? Back

J. Puga
The use of the internal mammary artery for revascularization of the left anterior descending coronary artery
Eur Heart J 1995 16: 21-25; doi:10.1093/eurheartj/16.suppl_E.21 [PDF] [Request Permissions]  

J. L. Pomar
The use of autologous saphenous vein grafts for isolated left anterior descending coronary artery revascularization
Eur Heart J 1995 16: 26-28; doi:10.1093/eurheartj/16.suppl_E.26 [PDF] [Request Permissions]  

Angioplasty or Surgery? Back

C. L. Grines and W. W. O'Neill
Multivessel angioplasty versus bypass surgery: A case for PTCA
Eur Heart J 1995 16: 29-31; doi:10.1093/eurheartj/16.suppl_E.29 [PDF] [Request Permissions]  

B. J. Gersh
The management of patients with stable angina and multivessel disease: PTCA or coronary bypass surgery?
Eur Heart J 1995 16: 32-35; doi:10.1093/eurheartj/16.suppl_E.32 [PDF] [Request Permissions]  

Anti-Anginal Therapy after Infarction Back

P. Sleight
Are antianginal drugs effective in post-myocardial infarction secondary prevention?
Eur Heart J 1995 16: 36-37; doi:10.1093/eurheartj/16.suppl_E.36 [PDF] [Request Permissions]  

D. G. Julian
Are antianginal drugs effective in secondary prevention after myocardial infarction?
Eur Heart J 1995 16: 38-40; doi:10.1093/eurheartj/16.suppl_E.38 [PDF] [Request Permissions]  

ACE Inhibitors in MI Back

R. Prashad and G. A. Lamas
Should ACE inhibitors be administered to all patients with acute myocardial infarction?
Eur Heart J 1995 16: 41-43; doi:10.1093/eurheartj/16.suppl_E.41 [PDF] [Request Permissions]  

D. G. Julian
Should ACE inhibitors be administered to all patients after acute myocardial infarction?: A (cautious) negative response
Eur Heart J 1995 16: 44-45; doi:10.1093/eurheartj/16.suppl_E.44 [PDF] [Request Permissions]  

Treatment of Asymptomatic Ventricular Arrhythmias Back

R. W. F. Campbell
Should post-infarction asymptomatic ventricular arrhythmias be treated?
Eur Heart J 1995 16: 46-48; doi:10.1093/eurheartj/16.suppl_E.46 [PDF] [Request Permissions]  

P. Sleight
Should post-infarction asymptomatic ventricular arrhythmias be treated?: The need for caution
Eur Heart J 1995 16: 49; doi:10.1093/eurheartj/16.suppl_E.49 [PDF] [Request Permissions]  

Prognostic Effects of Modern Therapies Back

B. J. Gersh
The changing late prognosis of acute myocardial infarction: Implications and mechanisms
Eur Heart J 1995 16: 50-53; doi:10.1093/eurheartj/16.suppl_E.50 [PDF] [Request Permissions]  

A. P. M. Gorgels, J. W. M. G. Widdershoven, J. J. M. de Vreede-Swagemakers, L. W. N. Dijkman, W. Arbouw, F. Vermeer, and H. J. J. Wellens
Has the long-term prognosis of acute myocardial infarction improved with the new treatments?: The negative outlook
Eur Heart J 1995 16: 54-56; doi:10.1093/eurheartj/16.suppl_E.54 [PDF] [Request Permissions]  

J. Tamargo and J. López-Sendón
Relevance of the pharmacokinetic profile in the treatment of angina pectoris: the need for 24 h control
Eur Heart J 1995 16: 57-61; doi:10.1093/eurheartj/16.suppl_E.57 [PDF] [Request Permissions]  

J. E. Deanfield
Treatment effects on the total ischaemic burden and variables with prognostic implications
Eur Heart J 1995 16: 62-63; doi:10.1093/eurheartj/16.suppl_E.62 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.